SEC Company Response from Q (QCLS) — Apr 6, 2020
Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: April 6, 2020 · CIK: 0001321834 · Accession: 0001493152-20-005935
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234449
Letter
Akers Biosciences, Inc.
Grove Road
Thorofare, New Jersey 08086
April 6, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
Attention: Paul Fischer
Re:
Akers Biosciences, Inc.
Registration Statement on Form S-3, originally filed on November 1, 2019
File No. 333-234449 (the “Registration Statement”)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Akers Biosciences, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 9:30 a.m., Eastern Time, on April 7, 2020, or as soon thereafter as practicable.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very
truly yours,
AKERS
BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
Akers
Biosciences, Inc.
201
Grove Road
Thorofare,
New Jersey 08086
April
6, 2020
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
Attention:
Paul Fischer
Re:
Akers
Biosciences, Inc.
Registration
Statement on Form S-3, originally filed on November 1, 2019
File
No. 333-234449 (the “Registration Statement”)
Request
for Acceleration
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”)
under the Securities Act of 1933, as amended, Akers Biosciences, Inc. (the “Company”) hereby respectfully
requests acceleration of the effective date of the Registration Statement so that it may become effective at 9:30 a.m.,
Eastern Time, on April 7, 2020, or as soon thereafter as practicable.
Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel,
Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very
truly yours,
AKERS
BIOSCIENCES, INC.
By:
/s/
Christopher Schreiber
Christopher
Schreiber Executive Chairman of the Board of Directors and Director
cc:
Rick A. Werner, Esq., Haynes and Boone, LLP